HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment (Q57638728)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Colin Palmer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

S Ogston

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

J Berg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

C Fleming

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

V Kumar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

J Foerster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

17 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Dermatology

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

651-655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

The emerging era of pharmacogenomics: current successes, future potential, and challenges

20 March 2020

cites work

1 reference

Methotrexate for psoriasis in the era of biological therapy.

21 January 2018

1 reference

Methotrexate in psoriasis under real-world conditions: long-term efficacy and tolerability

21 January 2018

1 reference

Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis.

21 January 2018

1 reference

Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment

21 January 2018

1 reference

Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis

21 January 2018

1 reference

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms.

21 January 2018

1 reference

Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials

21 January 2018

1 reference

Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CED.13100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28512993%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference